Aberrant T cell-mediated responses and cytokine release (e.g., IL-17, IFN-γ, TNF-α) drive keratinocyte hyperproliferation and differentiation abnormalities while also affecting cardiovascular and metabolic systems, underscoring psoriasis as a systemic immune-mediated disorder [29]. Here, IL17A is linked to psoriasis.